Medexus Inc. is a Canadian-based, privately held Pharmaceutical Company. The Company operates through three business segments:
|A BUSINESS DEVELOPMENT segment, which licenses products, prescription and OTC, from international partners.|
|THE REGULATORY/ACCESS segment which prepares and submits dossiers for Health Canada approval, as well as preparing submissions for private and public reimbursement.|
|MARKETING/SALES segment. Medexus employs several people across Canada for business units.|
Medexus operates with an active Board of Directors including founder and President, Ken d’Entremont.
Medexus Inc. was founded in 2000 and was profitable by year 3. We employ highly qualified individuals, in key areas of marketing, sales, market access, regulatory, business development in Canada. Sales are increasing steadily and significant growth is expected, with aggressive business development and several new products ready for launch. Our efforts have not wavered. We continue to focus on bringing the safest and most effective prescription and OTC brands to the market for patients, consumers and healthcare professionals, improving quality of life.
COMPLIANCE & CORPORTATE RESPONSIBILITY
Medexus succeeds in the competitive arena by being innovative, quality-driven, reliable and fair. This means observing both company-specific and statutory regulations.
As a Canadian leader in pharmaceuticals, Medexus has a responsibility to act as a good corporate citizen. We recognize and perform the obligations we have towards our people, investors, customers, suppliers and the community as a whole. We believe our reputation, together with the trust and confidence of those with whom we deal, to be one of the most valuable assets. We believe that integrity is a prerequisite for a success in all areas of our business.